Your browser doesn't support javascript.
loading
Value of [11C]-Methionine PET/CT in Preoperative Localization of Parathyroid Adenomas.
Saerens, Julie; Velkeniers, Brigitte; Keyaerts, Marleen; Raeymaeckers, Steven; Vanhoeij, Marian; Blotwijk, Susanne; Bravenboer, Bert.
Afiliação
  • Saerens J; Department of Endocrinology, University Hospital Brussels, Jette, Belgium.
  • Velkeniers B; Department of Endocrinology, University Hospital Brussels, Jette, Belgium.
  • Keyaerts M; Department of Nuclear Medicine, University Hospital Brussels, Jette, Belgium.
  • Raeymaeckers S; Department of Radiology, University Hospital Brussels, Jette, Belgium.
  • Vanhoeij M; Department of Surgery, University Hospital Brussels, Jette, Belgium.
  • Blotwijk S; Interfaculty Center Data Processing and Statistics, Vrije Universiteit Brussel , Jette, Belgium.
  • Bravenboer B; Department of Endocrinology, University Hospital Brussels, Jette, Belgium.
Horm Metab Res ; 53(7): 444-452, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34169499
There are multiple imaging modalities in primary hyperparathyroidism. Ultrasound examination and subtraction scintigraphy are usually the first-line imaging techniques. When these results are negative or inconsistent, additional [11C]-methionine PET/CT (MET-PET/CT) or 4-dimensional computed tomography can be performed. ​This study aims to evaluate MET-PET/CT in comparison with other imaging techniques in primary hyperparathyroidism. This is a retrospective cohort study. Eighty-four patients with primary hyperparathyroidism, who underwent parathyroid surgery, were included. ​Imaging results have been correlated to the perioperative drop in parathyroid hormone level and to the pathological analysis. ​Descriptive statistics are used, supplemented with 95% Clopper-Pearson confidence intervals for sensitivity and specificity and a sub-analysis with the McNemar test on paired data only. The per-lesion sensitivity of MET-PET/CT seems higher than that of [99mTc]-sestamibi or [99mTc]-tetrofosmin and [99mTc]-pertechnetate subtraction scintigraphy. The McNemar test, on paired data only, shows significantly higher sensitivity of MET-PET/CT compared to ultrasound (p=0.039) and significantly higher specificity of ultrasound compared to subtraction scintigraphy (p=0.035).​ MET-PET/CT after inconclusive or negative ultrasound and/or subtraction scintigraphy has an additional value in 70% of the cases.​ Preoperative parathyroid hormone levels were higher in patients in whom MET-PET/CT correctly predicted the pathological parathyroid glands, compared to those where MET-PET/CT missed at least one adenoma. The same trend was seen for 4-dimensional computed tomography. In conclusion, MET-PET/CT seems a valuable imaging modality in primary hyperparathyroidism, at least as second line imaging approach, with a higher per-lesion sensitivity than ultrasound in such setting. Especially when ultrasound and/or subtraction scintigraphy are inconclusive or negative, MET-PET/CT directs the surgeon to the correct localization of the parathyroid adenoma.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Paratireoides / Radioisótopos de Carbono / Adenoma / Metionina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Paratireoides / Radioisótopos de Carbono / Adenoma / Metionina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article